Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ABEONA THERAPEUTICS INC.Abeona Therapeutics Reports $91.6 Million Net Income and Significant Asset Growth in Latest 10-Q
Hyliion Holdings Corp.Hyliion Reports $759,000 Revenue in Q3 2025, Net Loss of $13.3 Million
Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports $12.5 Million Net Loss for Third Quarter 2025
ImageneBio, Inc.ImageneBio Reports $24.8 Million Net Loss in Q3 2025, Increases R&D Spending
Marathon Bancorp, Inc. /MD/Marathon Bancorp Reports 154% Increase in Net Income for Q3 2025
reAlpha Tech Corp.reAlpha Tech Corp. Reports 326% Revenue Growth to $1.45 Million in Q3 2025
TScan Therapeutics, Inc.TScan Therapeutics Reports Q3 2025 Revenue Growth but Increased Net Loss
Opus Genetics, Inc.Opus Genetics Reports $17.5 Million Net Loss in Q3 2025, Focuses on Gene Therapy Programs
TIC Solutions, Inc.TIC Solutions Reports 56% Revenue Growth to $473.9 Million in Q3 2025
McGraw Hill, Inc.McGraw Hill Reports $669.2 Million Revenue, 2.8% Decline in Latest Quarter
Palladyne AI Corp.Palladyne AI Corp. Reports Q3 2025 Financial Results with Revenue Decline and Increased Loss
Prelude Therapeutics IncPrelude Therapeutics Reports Revenue Increase and Reduced Losses in Q3 2025
Charlotte's Web Holdings, Inc.Charlotte's Web Holdings Reports Decline in Revenue and Increased Net Loss for Q3 2025
ROCKWELL MEDICAL, INC.Rockwell Medical Reports 44% Decline in Q3 2025 Net Sales, Driven by Reduced Sales to DaVita
ProMIS Neurosciences Inc.ProMIS Neurosciences Reports $11.6M Net Loss in Q3 2025 Amid Rising Expenses
Artiva Biotherapeutics, Inc.Artiva Biotherapeutics Reports Q3 2025 Financial Results with Increased Net Loss
Inflection Point Acquisition Corp. VMaywood Acquisition Corp. Reports Q3 2025 Net Income of $70,891, Significant Asset Growth Following IPO
New Concept Energy, Inc.New Concept Energy Reports Q3 2025 Financial Results with Increased Revenues but Higher Net Loss
PYXUS INTERNATIONAL, INC.Pyxus International Reports Improved Net Loss of $902,000 for Q2 2025
Ovid Therapeutics Inc.Ovid Therapeutics Reports Q3 2025 Revenue Decline and Net Loss Amid Increased Year-to-Date Revenue
Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals Reports $1.99 Million Net Loss in Q3 2025, Down 29% Year-Over-Year
CROWN CRAFTS INCCrown Crafts Reports Decline in Sales and Gross Profit for Recent Periods
Bespoke Extracts, Inc.Bespoke Extracts Reports 69% Sales Increase and Reduced Net Losses in Q3 2025
Milestone Pharmaceuticals Inc.Milestone Pharmaceuticals Reports $11.9M Net Loss in Q3 2025, Prepares for Etripamil Launch
Unicycive Therapeutics, Inc.Unicycive Therapeutics Reports Q3 2025 Financial Results with Increased Net Loss